<DOC>
	<DOCNO>NCT02183675</DOCNO>
	<brief_summary>To assess drug drug interaction pharmacokinetics investigation steady state Telmisartan , Amlodipine , Hydrochlorothiazide ( HCTZ ) give three different formulation healthy Japanese male subject</brief_summary>
	<brief_title>Pharmacokinetics Different Formulations Telmisartan , Amlodipine , Hydrochlorothiazide ( HCTZ ) Japanese Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion : Healthy Japanese male subject age &gt; =20 &lt; =35 year ; body weight : &gt; =50 kg &lt; =80 kg ; body mass index : &gt; =18.0 &lt; =25.0 kg/m2 Without clinically significant finding complication basis complete medical history , include physical examination , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) , body temperature ) , 12lead electrocardiogram ( ECGs ) , clinical laboratory test Signed date write informed consent prior admission trial accordance Good Clinical Practice ( GCP ) local legislation . Exclusion criterion : Any find medical examination ( include BP , PR ECGs ) deviate normal clinical relevance .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>